Goodwill of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Goodwill in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Goodwill for the quarter ending 30 Sep 2025 was $119,080,000, a 1.8% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $119,080,000 +$2,061,000 +1.8% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $117,019,000 $0 0% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $117,019,000 $0 0% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $117,019,000 $0 0% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $117,019,000 $0 0% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $117,019,000 $0 0% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $117,019,000 $0 0% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $117,019,000 $0 0% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $117,019,000 -$364,000 -0.31% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $117,019,000 +$1,605,000 +1.4% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $117,019,000 +$1,605,000 +1.4% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $117,019,000 -$497,000 -0.42% 31 Dec 2022 10-Q 08 Nov 2023 2023 Q3
Q3 2022 $117,383,000 +$39,420,000 +51% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $115,414,000 +$37,451,000 +48% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $115,414,000 +$37,503,000 +48% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $117,516,000 +$39,605,000 +51% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $77,963,000 -$11,180,000 -13% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $77,963,000 -$10,132,000 -12% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $77,911,000 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $77,911,000 +$77,911,000 31 Dec 2020 10-K 13 Apr 2022 2021 FY
Q3 2020 $89,143,000 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $88,095,000 30 Jun 2020 10-Q 17 Aug 2020 2020 Q2
Q4 2019 $0 31 Dec 2019 10-K 08 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.